Evaluation of pediatric HIV care provided in Ryan White CARE Act Title IV Women, Infants, Children, and Youth Clinics

AIDS Patient Care and STDs

Volumn 17, Issue 2, 2003, Pages 65-73

  Caudill, Samantha ^a   Goldman, Thurma ^a   Marconi, Katherine ^a  

^a HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; COTRIMOXAZOLE;

ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HERPES SIMPLEX; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERSTITIAL PNEUMONIA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL PRACTICE; MEDICAL RECORD; MYCOBACTERIUM INTRACELLULARE AVIUM; OPPORTUNISTIC INFECTION; PATIENT CARE; PNEUMOCYSTIS PNEUMONIA; SOCIOECONOMICS; TREATMENT OUTCOME; UNITED STATES; VIRUS LOAD;

EID: 0037323596     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729103321150791     Document Type: Article

References (12)

1. HIV Surveillance Report. Department of Health and Human Services, Centers for Disease Control and Prevention. 2001;12:2.
2. Pediatric HIV/AIDS Surveillance, L262 Slide Series (through 2000). Department of Health and Human Services, Centers for Disease Control and Prevention. Available: www.cdc.gov/hiv/graphics/pediatric.htm.
3. Public Law 102-381. Ryan White CARE Act. 1990 (August 18) and Public Law 106-345. Ryan White CARE Act 2000 (October 20).
4. Abramowitz S, Obten N. Ryan White CARE Act Title IV: building networks to improve healthcare delivery to the HIV infected. AIDS Public Policy J 2000;15:17-28.
5. 2000 Title IV Data Slides. Department of Health and Human Services, Health Resources and Services Administration. Available: ftp://ftp.hrsa.gov/hab/tiv2000-rep.pdf.
6. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Department of Health and Human Services, National Library of Medicine. Available: www.hivatis.org.
7. Combination nucleoside analog revise transcriptase inhibitor(s) plus nevirapine, nelfinavir, or titonavir in stable antiretroviral therapy-experienced HIV-infected children; Pediatric AIDS Clinical Trials Group 377 Study Team. AIDS Res Hum Retroviruses 2000; 16:1113-1121.
8. Dankner WM, Lindsey JC, Levin MJ, et al. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J 2001;20:40-48.
9. Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors. AIDS Res Hum Retroviruses 2001;17:1117-1123.
10. Classification System for (HIV) Infection in Children Under 13; Department of Health and Human Services, Centers for Disease Control and Prevention. Available: www.cdc.gov/epo/mmwr/preview/mmwrhtml/00033741.htm.
11. Lindgren ML, Steinberg S, Byers RH. Epidemiology of HIV/AIDS in children. Pediatr Clin North Am 2000;47:1-20.
12. England JA, Baker CJ, Rasinko C, et al. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. N Engl J Med 1997; 336:1704-1712.